Dr. Sara Spettel , MD
Urology • Portland, OR
9135 Sw Barnes Rd, Suite 663
Portland, OR 972256646
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 7, 2008; this date does not establish years in practice.
-
Published CMS data list 9,212 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J0585 — Injection, onabotulinumtoxina, 1 unit: 7,500 service units.
- G2211 — Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 366 service units.
- 99214 — Established patient outpatient office visit: 347 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 13 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,840 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 947 prescription fills, including refills.
- Finasteride — 661 prescription fills, including refills.
- Nitrofurantoin (Nitrofurantoin Macrocrystal) — 275 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 16 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Urology in Portland, OR (2024, 36 clinicians with data). Median for this group: 721. Middle half: 220 to 1,646.
More Medicare Part B services than 95% of clinicians listed under Urology in Oregon (2024, 100 clinicians with data). Median for this group: 1,172. Middle half: 390 to 3,233.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 8,057 in 2020 to 9,212 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
9135 Sw Barnes Rd
Suite 663
Portland, OR 972256646
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Northwest Urology Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
2008
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
483 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $227,469 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $172,808 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
4,999 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$107,389 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,637.00 across 93 records.
By nature of payment
- Food and Beverage: $2,637.00 across 93 records.
Reporting-company totals (3 largest of 31)
- Sumitomo Pharma America, Inc.: $272.43 across 8 records.
- Janssen Pharmaceuticals, Inc: $212.22 across 7 records.
- TOLMAR, INC.: $188.52 across 5 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
18 years (graduated 2008)
CMS Doctors and Clinicians data list 2008 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Spettel has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Spettel as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Portland and Oregon
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Urology in Portland, OR (2024, 36 clinicians with data). Median for this group: 721. Middle half: 220 to 1,646.
More Medicare Part B services than 95% of clinicians listed under Urology in Oregon (2024, 100 clinicians with data). Median for this group: 1,172. Middle half: 390 to 3,233.
Medicare-allowed amount
A higher Medicare-allowed amount than 85% of clinicians listed under Urology in Portland, OR (2024, 36 clinicians with data). Median for this group: $70,347. Middle half: $24,851 to $143,202.
A higher Medicare-allowed amount than 85% of clinicians listed under Urology in Oregon (2024, 100 clinicians with data). Median for this group: $85,027. Middle half: $37,468 to $161,039.
Paid by Medicare
A higher Medicare payment amount than 85% of clinicians listed under Urology in Portland, OR (2024, 36 clinicians with data). Median for this group: $50,253. Middle half: $19,075 to $105,936.
A higher Medicare payment amount than 85% of clinicians listed under Urology in Oregon (2024, 100 clinicians with data). Median for this group: $62,691. Middle half: $29,551 to $119,989.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Urology in Portland, OR (2024, 42 clinicians with data). Median for this group: 445. Middle half: 141 to 1,542.
More Part D prescriptions than 90% of clinicians listed under Urology in Oregon (2024, 132 clinicians with data). Median for this group: 892. Middle half: 374 to 1,476.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Urology in Portland, OR (2024, 42 clinicians with data). Median for this group: $45,834. Middle half: $5,454 to $144,730.
A higher Part D drug cost than 60% of clinicians listed under Urology in Oregon (2024, 132 clinicians with data). Median for this group: $56,171. Middle half: $15,982 to $201,113.
69 active clinicians are listed under Urology with a practice address in Portland, OR (190 in Oregon).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Portland
50.7% of these 69 clinicians have the CMS telehealth indicator.
69.6% of these 69 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 14% from 8,057 in 2020 to 9,212 in 2024.
- 2020: 8,057
- 2021: 7,584
- 2022: 9,057
- 2023: 9,458
- 2024: 9,212
-
Medicare-allowed amount
Medicare-allowed amount increased 30% from $175,598 in 2020 to $227,469 in 2024.
- 2020: $175,598
- 2021: $213,460
- 2022: $201,786
- 2023: $228,684
- 2024: $227,469
-
Paid by Medicare
Paid by Medicare increased 31% from $131,894 in 2020 to $172,808 in 2024.
- 2020: $131,894
- 2021: $164,469
- 2022: $155,300
- 2023: $175,548
- 2024: $172,808
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 19% from 2,396 in 2020 to 2,840 in 2024.
- 2020: 2,396
- 2021: 2,173
- 2022: 1,888
- 2023: 2,525
- 2024: 2,840
-
30-day fills
30-day fills increased 40% from 3,565 in 2020 to 4,999 in 2024.
- 2020: 3,565
- 2021: 3,629
- 2022: 3,305
- 2023: 4,401
- 2024: 4,999
-
Part D drug cost
Part D drug cost decreased 60% from $270,878 in 2020 to $107,389 in 2024.
- 2020: $270,878
- 2021: $97,460
- 2022: $91,294
- 2023: $120,692
- 2024: $107,389
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 40% from $4,383.35 in 2021 to $2,637.00 in 2025.
- 2021: $4,383.35
- 2022: $1,094.41
- 2023: $1,762.67
- 2024: $2,077.96
- 2025: $2,637.00
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 93 records totaling $2,637.00.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Dornier MedTech America, Inc |
Food and Beverage
In-kind items and services
|
Dornier MedTech | General | $142.53 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $123.67 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
RYBREVANT | General | $121.88 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $117.84 |
| TOLMAR, INC. |
Food and Beverage
In-kind items and services
|
JATENZO | General | $85.83 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Trelstar | General | $66.22 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $41.55 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $39.59 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $37.40 |
| Telix Pharmaceuticals |
Food and Beverage
In-kind items and services
|
ILLUCCIX | General | $36.28 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
LYNPARZA | General | $35.74 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
— | General | $35.22 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.66 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $33.19 |
| TOLMAR, INC. |
Food and Beverage
Cash or cash equivalent
|
RUBRACA | General | $31.21 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Rezum Generator | General | $30.43 |
| ConvaTec Inc. |
Food and Beverage
In-kind items and services
|
CURE CATHETER | General | $29.66 |
| Boston Scientific Corporation |
Food and Beverage
In-kind items and services
|
Axonics | General | $29.56 |
| Endo USA, Inc. |
Food and Beverage
In-kind items and services
|
AVEED | General | $29.13 |
| ACCORD HEALTHCARE, INC. |
Food and Beverage
In-kind items and services
|
Camcevi | General | $29.00 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
ORGOVYX | General | $28.83 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $28.63 |
| ConvaTec Inc. |
Food and Beverage
In-kind items and services
|
CURE CATHETER | General | $28.25 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $28.08 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
ZUSDURI | General | $27.92 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J0585
Injection, onabotulinumtoxina, 1 unit
|
7,500 | 29 | $14.00 | $6.11 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
366 | 285 | $48.00 | $16.72 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
347 | 243 | $365.93 | $131.43 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
263 | 218 | $51.00 | $12.35 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
206 | 206 | $476.93 | $173.62 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
161 | 139 | $259.94 | $94.03 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
136 | 113 | $695.00 | $252.45 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
74 | 53 | $161.97 | $58.80 |
|
81002
Urinalysis, manual test
|
52 | 47 | $7.88 | $3.34 |
|
52287
Exam with injections of chemical for destruction of bladder using an endoscope
|
49 | 29 | $1127.00 | $411.45 |
|
52310
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope
|
26 | 26 | $913.00 | $315.48 |
|
52356
Crushing of stone of ureter with insertion of stent using an endoscope
|
18 | 16 | $1179.15 | $393.97 |
|
52332
Insertion of stent in ureter using an endoscope
|
14 | 14 | $468.93 | $103.78 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 947 | 55,251 | $9,587.53 | 272 |
| Finasteride | Finasteride | 661 | 42,553 | $6,446.94 | 175 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 275 | 8,868 | $7,095.89 | 100 |
| Solifenacin Succinate | Solifenacin Succinate | 268 | 11,777 | $5,413.02 | 63 |
| Estradiol | Estradiol | 217 | 13,154 | $14,440.28 | 96 |
| Cephalexin | Cephalexin | 122 | 4,429 | $1,236.57 | 41 |
| Oxybutynin Chloride | Oxybutynin Chloride | 48 | 1,127 | $498.60 | 40 |
| Myrbetriq | Mirabegron | 47 | 1,822 | $26,323.56 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 39 | 184 | $159.88 | 37 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 38 | 1,733 | $586.96 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 38 | 167 | $192.31 | 30 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 34 | 1,235 | $1,454.82 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 109 | $133.41 | 31 |
| Gemtesa | Vibegron | 33 | 2,100 | $33,075.50 | 13 |
| Trimethoprim | Trimethoprim | 21 | 690 | $502.81 | — |
| Sodium Chloride | Sodium Chloride Irrig Solution | 19 | 468 | $240.68 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20130829000078
OR
3375786916
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Northwest Urology Llc
9135 Sw Barnes Rd, Portland, OR 972256683
Phone: 5032971078
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 07, 2008.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Urology Specialists in Portland
- Dr. Jacob Richard, MD
- Thien-Linh Le Forsyth
- Dr. Miguel Rodriguez-Homs, MD
- Dr. Amanda Vandlac, MD
- Lauren Lamina
- Dr. Ehud Zusman, MD
Mailing Address
9135 Sw Barnes Rd, Suite 663
Portland, OR 972256646
Phone: 5032971078